Archive: Jan 2018

Happi: FDA Is Getting Personal

Posted on January 9th, 2018, by Bell International Laboratories in Blog Post

Warning letters reiterate Agency priorities, target consumer reviews and trigger consumer class actions. Authors: Raqiyyah Pippins and Krithika Santhanam Click here for Original story on By now, it is no secret that the Food and Drug Administration (FDA) is monitoring personal care product marketing and using warning letters to remind companies of what causes a product […]